Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric‐Onset Hypophosphatasia
To read more please click on the link below.
Read Article
Related Articles
Safety, pharmacokinetics, and pharmacodynamics of efzimfotase alfa, a second-generation enzyme replacement therapy: phase 1, dose-escalation study in adults with hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Improvement in quality of life after asfotase alfa treatment in adults with pediatric-onset hypophosphatasia: data from 5 patient-reported outcome measures
Print 🖨 PDF 📄To read more please click on the link below. Read Article
Responses